Antibody-drug conjugates (ADCs) represent a revolutionary advancement in the battle with cancer. ADCs combine the specificity of antibodies with the lethal force of cytotoxic drugs. By transporting these potent agents directly to cancer cells, ADCs amplify treatment efficacy while minimizing harm to healthy tissues . This targeted approach holds si